Effect of Asfotase Alfa in the Treatment of Hypophosphatasia- A Systematic Review

Hypophosphatasia (HPP) is a life-threatening disease that occurs due to the mutation of the TNSALP (Tissue nonspecific isoenzyme of alkaline phosphatase) encoding gene. There is no approved treatment for Hypophosphatasia. Therefore, the only effective treatment for HPP is enzyme replacement therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaswanthi, N, Sindhu, R, Nimmy, P, Prabu, D, RajMohan, M, Bharathwaj, VV, Dhamodhar, Dinesh, Sathiyapriya, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466581/
https://www.ncbi.nlm.nih.gov/pubmed/37654393
http://dx.doi.org/10.4103/jpbs.jpbs_662_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466581/
https://www.ncbi.nlm.nih.gov/pubmed/37654393
http://dx.doi.org/10.4103/jpbs.jpbs_662_22

Ejemplares similares